Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Psychoneuroendocrinology. 2014 Apr 6;45:142–153. doi: 10.1016/j.psyneuen.2014.03.018

Figure 2.

Figure 2

Body weight, adrenal weight, and thymus weight of rats with bilateral NTS micropellets. (A) 30 μg of CHOL, CORT or mifepristone micropellets implantation on the NTS does not alter body weight in the absence of stress (experiment 1, n=8-10/group). (B) NTS mifepristone micropellet (30 μg) and CVS-induced percent change in body weight. (C) Adjusted adrenal weight is increased by both CVS exposure and NTS mifepristone micropellet implants. (D) CVS exposure reduced adjusted thymi weight relative to no CVS control. Data are shown as mean ± SEM (n=8-12 per group). *p <0.05 vs. no CVS. #p <0.05 vs. CHOL.

HHS Vulnerability Disclosure